KASSBERG THOMAS RICHARD (CBO & EVP) sold 2.2% of their position (6.03K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $253.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/4/2025ACC: 0000950170-25-032802
Officer· CBO & EVP
Since Mar 2019
+11.91K
Net shares
Net buyer
$275.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
18.44K acquired · 6.54K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+18.44K
Price / share
—
Trade value
—
% of position
7.3%
3/1/2025
252.82K→271.27K
Common Stock
Direct
Shares
−6.03K
Price / share
$42.10
Trade value
$253.78K
% of position
2.2%
3/3/2025
271.27K→265.24K
Common Stock
Direct
Shares
−508.00
Price / share
$42.92
Trade value
$21.80K
% of position
0.2%
3/3/2025
265.24K→264.73K
Total
Net shares
+11.91K
Net value
-$275.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2025 | A · Award | +18.44K | — | — | 7.3% | 252.82K | 271.27K |
| Common Stock Direct | 3/3/2025 | S · Sale | −6.03K | $42.10 | $253.78K | 2.2% | 271.27K | 265.24K |
| Common Stock Direct | 3/3/2025 | F · Tax Withholding | −508.00 | $42.92 | $21.80K | 0.2% | 265.24K | 264.73K |
| Total | +11.91K | -$275.58K | ||||||
Derivative Transactions0
No derivative transactions reported